Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.

Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.

http://www.wikidata.org/entity/Q33572429

about

Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis.Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80.Ginseng and male reproductive function White Ginseng Protects Mouse Hippocampal Cells Against Amyloid-Beta Oligomer Toxicity.Pharmacokinetics of ginsenoside Rg1 in rat medial prefrontal cortex, hippocampus, and lateral ventricle after subcutaneous administration.Ginsenoside Rg1 modulates medial prefrontal cortical firing and suppresses the hippocampo-medial prefrontal cortical long-term potentiation.Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study

P2860

Q35146624-4A9446A8-81B6-499F-A0DF-A0344D726B66 Q38263144-0F6397A1-895E-4E5D-8AEC-2189DED047A0 Q38752226-99EF8293-DD5F-484E-AE94-DE6FA8212342 Q42804267-E531561B-59B9-4AB6-869B-EB0E0E6CA6C4 Q48344833-1B66A9D4-25B7-47A7-9FF7-E9E1E4FB8508 Q48665149-1460D886-6416-4E9C-B10F-151F0101B645 Q55464472-77F1555C-74CA-43F5-B0F3-3ABD1C6287A1 Q57493673-F5F73B2F-E714-4B46-ABC9-38FD3B36E642

P2860

Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.

http://www.wikidata.org/entity/Q33572429

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@ast

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@en

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@nl

type

label

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@ast

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@en

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@nl

prefLabel

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@ast

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@en

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@nl

P1433

Q33572429-AFE82193-4DE4-43AF-A972-05C5854FBDA9

P1476

Q33572429-FBAFF4FE-9796-4F25-8919-7717508DD4DF

P2093

Q33572429-0E07F154-3499-4E09-99F0-98DA82EA881D

Q33572429-1EAADB16-2C1D-4BCA-8A64-6FEC9A7DF0F0

Q33572429-3F449654-E84E-4DB9-8F5B-C221CCC6F95C

Q33572429-7C701D0C-05D8-430E-9A13-BB5A3E02D22B

P2860

Q33572429-02D118DC-B2B4-4338-9703-3DA4EA7B16E2

Q33572429-0554E801-7127-4B15-AD46-1FA34EC75D2B

Q33572429-08F9E2D5-B9DF-4B22-9D82-0CC5C6F32378

Q33572429-1B99A144-60E4-4065-A952-92A6684A3DAC

Q33572429-1ED09A45-1420-4F1B-867E-5D664315008C

Q33572429-275C0AFF-1239-4729-9427-97818B33A93F

Q33572429-2D609788-922E-4BD8-9FFA-168CF9BCF84B

Q33572429-371A9684-AC47-4849-AD4E-54577671B5F5

Q33572429-3D13E38F-BA76-4B85-860A-A6597FAA45E2

Q33572429-509F64FB-2819-479F-8011-A40958DC5777

P2888

Q33572429-88D6C6FF-A576-4420-9E5D-128EE4FDE5D8

P304

Q33572429-B98ECE47-516A-46F0-A977-A9B388C0758E

P31

Q33572429-371D4E98-FD85-46A3-801B-4F2C3EABF42B

P356

Q33572429-7836FA87-8BBF-4A80-A6E1-1EDE9ACDB9DB

P433

Q33572429-303FD33D-2A8D-4A1F-B3D4-43B660DDAD74

P478

Q33572429-63C702A5-3DF2-4C86-B129-860A8946EFA9

P577

Q33572429-564F63D3-9C77-49E1-82AE-912B6010C80A

P5875

Q33572429-3963E1BA-3256-40E9-8AE9-4DB01BD75DC3

P6179

Q33572429-ED5AB132-F96B-4B28-ABC4-508F348D56EB

P698

Q33572429-25CDB456-CB26-4C82-A80E-C2712ED6E4A2

P921

Q33572429-485799ba-7a99-4b32-b66c-46bb49460d85

Q33572429-D09A7FCE-574B-4434-A49A-96EC5AA4323B

P932

Q33572429-654652DA-CC58-4F9E-B7BC-4AD031BCA08C

P356

P1433

Acta Pharmacologica Sinica

P1476

Pharmacokinetics and dopamine/ ...... nd mPFC of freely moving rats.

@en

P2093

Jing Shi

http://www.w3.org/2001/XMLSchema#string

Ke-xin Li

http://www.w3.org/2001/XMLSchema#string

Wei Xue

http://www.w3.org/2001/XMLSchema#string

Wen-jie Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterases, a target of pharmacology and toxicology

N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.

Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers

Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function.

Disturbed neurotransmitter transporter expression in Alzheimer's disease brain

Ginsenoside Re: Its chemistry, metabolism and pharmacokinetics

Cancer prevention and therapeutics: Panax ginseng.

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.

A survey of TCM treatment for Alzheimer's disease.

P2888

P304

214-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2012.147

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233829105

http://www.w3.org/2001/XMLSchema#string

P6179

1036890583

http://www.w3.org/2001/XMLSchema#string

P698

23202798

http://www.w3.org/2001/XMLSchema#string

P921

P932

4011622

http://www.w3.org/2001/XMLSchema#string